Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jacobson

Showing results (211-220 of 1,486) with videos related to

Pageof 149
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal treatment with telaprevir for chronic HCV infectionArun B Jesudian, Ira M Jacobson
Antiviral Therapy|November 29, 2012
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevirKristen M Marks, Ira M Jacobson
Journal of Oncology Practice|September 22, 2010
Ethical issues related to patient use of complementary and alternative medicineGeraldine M Jacobson, Joanna Mary Cain
JAMA|November 3, 1978
Accessory spleen in Hodgkin's diseaseJ M Jacobson, R D Reynolds
Current Opinion in Pediatrics|June 3, 1998
The genetic basis for variation in antibody response to vaccinesG A Poland, R M Jacobson
Frontiers in Oncology|October 7, 2017
Low-Energy Intraoperative Radiation Therapy and Competing Risks of Local Control and Normal Tissue ToxicityGeraldine M Jacobson, Ramon Alfredo Siochi
Seminars in Liver Disease|September 1, 2007
Halting the natural history of hepatitis B viral infection: a paradigm shiftRobert P Perrillo, Ira M Jacobson
American Journal of Preventive Medicine|May 30, 2007
Protecting patients from harm: legislating vaccinations for healthcare workersGregory A Poland, Robert M Jacobson
Vaccine|March 10, 2005
Studies of equivalence in clinical vaccine researchRobert M Jacobson, Gregory A Poland
The Journal of Heredity|March 25, 2005
A first assessment of genetic variation among Morchella esculenta (morel) populationsH J Dalgleish, K M Jacobson
Pageof 149

Showing results (211-220 of 1,486) with videos related to

Sort By:
Pageof 149
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal treatment with telaprevir for chronic HCV infectionArun B Jesudian, Ira M Jacobson
Antiviral Therapy|November 29, 2012
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevirKristen M Marks, Ira M Jacobson
Journal of Oncology Practice|September 22, 2010
Ethical issues related to patient use of complementary and alternative medicineGeraldine M Jacobson, Joanna Mary Cain
JAMA|November 3, 1978
Accessory spleen in Hodgkin's diseaseJ M Jacobson, R D Reynolds
Current Opinion in Pediatrics|June 3, 1998
The genetic basis for variation in antibody response to vaccinesG A Poland, R M Jacobson
Frontiers in Oncology|October 7, 2017
Low-Energy Intraoperative Radiation Therapy and Competing Risks of Local Control and Normal Tissue ToxicityGeraldine M Jacobson, Ramon Alfredo Siochi
Seminars in Liver Disease|September 1, 2007
Halting the natural history of hepatitis B viral infection: a paradigm shiftRobert P Perrillo, Ira M Jacobson
American Journal of Preventive Medicine|May 30, 2007
Protecting patients from harm: legislating vaccinations for healthcare workersGregory A Poland, Robert M Jacobson
Vaccine|March 10, 2005
Studies of equivalence in clinical vaccine researchRobert M Jacobson, Gregory A Poland
The Journal of Heredity|March 25, 2005
A first assessment of genetic variation among Morchella esculenta (morel) populationsH J Dalgleish, K M Jacobson
Pageof 149